Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Phase II Multicenter Clinical Trial of Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Sponsor: Assaf-Harofeh Medical Center
A PHASE2 clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by Assaf-Harofeh Medical Center and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2023 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assaf-Harofeh Medical Center
- Rabin Medical Center
- Rambam Health Care Campus
- Sheba Medical Center
- Soroka University Medical Center
- Tel-Aviv Sourasky Medical Center
- Western Galilee Hospital-Nahariya
For direct contact, visit the study record on ClinicalTrials.gov .